A function for FGF-type peptide growth factors has been implied for early mesodermal patterning events in Xenopus laevis. FGF signalling operates via the MAP kinase cascade that can directly activate the transcription of organizer-expressed genes, such as Xbra and Xegr-1. We have recently provided evidence for a critical role of Ets-type transcription factors in FGF mediated Xegr-1 transcription activation. Here, we report on the identification of the Xenopus Ets-type protein ER81 that is expressed in a pattern overlapping with the ones of Xegr-1 and Xbra during gastrulation. Microinjection of XER81 encoding mRNA into ventral blastomeres of Xenopus embryos results in the induction of ectopic, tail-like protrusions, whereas dorsal overexpression results in disturbed eye development. In the animal cap assay, ectopic expression of XER81 is found to interfere with activin mediated induction of Xegr-1 and gsc, but not with the Xbra response to activin.
Introduction
Mesoderm induction in Xenopus embryogenesis is governed by the activity of diffusible signalling molecules which fall into different subfamilies as defined on the basis of the distinct signal transduction pathways utilized (reviewed in Harland and Gerhart, 1997) . One such signal transduction pathway that has been demonstrated to be involved in early mesodermal differentiation is the FGFinduced MAP kinase (MAPK) cascade (Whitman and Melton, 1992; MacNicol et al., 1993; Hartley et al., 1994; Gotoh et al., 1995; LaBonne et al., 1995; Northrop et al., 1995; Umbhauer et al., 1995; LaBonne and Whitman, 1997) . FGF signals appear to be important for mesoderm induction or maintenance, but not for dorso-ventral patterning. Quite a number of studies, making use of either the animal cap system and/or RNA injection into Xenopus embryos, have addressed the role of the different elements of the FGF dependant signal transduction pathway in mesoderm formation. It has been demonstrated that FGF induces mesoderm in animal caps (Kimelman and Kirschner, 1987; Slack et al., 1987; Grunz et al., 1988) , a dominant negative version of the FGF receptor prevents mesoderm formation in the embryo (Amaya et al., 1991) , constitutively active ras induces and dominant negative ras inhibits mesoderm formation (Whitman and Melton, 1992; LaBonne and Whitman, 1994) , raf (MAPK kinase kinase) induces, dominant negative raf prevents mesoderm formation (MacNicol et al. 1993; LaBonne and Whitman, 1994) , and finally, injection of active MAPK induces and dominant negative MAPK or MAPK-phosphatase inhibits mesoderm formation (LaBonne et al., 1995; Umbhauer et al., 1995) . On the other hand, transcription factors that are activated in the context of mesoderm induction via the MAPK signal transduction pathway in Xenopus embryos, or their direct target genes, are only poorly defined.
The transcription factor encoding gene Xbra is thought to be directly regulated by FGF, and a regulatory loop, that maintains Xbra expression in the early embryonic mesoderm and appears to operate via Xbra mediated activation of a gene encoding an FGF-type signalling molecule, has been defined (Isaacs et al., 1994; Schulte-Merker and Smith, 1995; Tang et al., 1995) . Transcription factors mediating the FGF response on the level of the Xbra promoter remain to be identified (Artinger et al., 1997; Latinkic et al., 1997) .
We have recently identified a zinc finger protein encoding gene, Xegr-1, that is similarly expressed in the early embryonic mesoderm and that responds directly to the MAPK signal transduction pathway in the animal cap system; Xegr-1 transcription can be activated by MAPK through the activity of two different transcription factors, SRF (serum response factor) and an Ets-type protein, which assemble into a ternary complex on the serum response elements (SREs) present in the 5′-flanking region of the Xegr-1 gene . However, the identity of the Ets-type protein that mediates the Xegr-1 response to FGF in the living Xenopus embryo remains to be revealed.
One subclass of Ets-type proteins is capable of forming a ternary complex (TCF-subclass) and a second one (Ets-1 subclass) contains proteins which can by themselves form specific DNA-protein complexes, but are unable to assemble into a ternary complex (reviewed in Treisman, 1996; Wasylyk and Nordheim, 1997) .
Several members of the Ets-1 subclass have been described in Xenopus; these include Xl-Ets-1, Xl-Ets-2 and Xl-fli (Wolff et al., 1991; Meyer et al., 1993; Stiegler et al., 1993) . Xl-Ets-1 and Xl-Ets-2 are maternally expressed and found to be present in the early embryonic mesoderm (Meyer et al., 1997) ; in contrast, Xl-fli is not detected before neurulation (Meyer et al., , 1995 . Overexpression of Xl-fli in Xenopus embryos has been found to result in anomalies of head and heart development, as well as in a disturbed erythroid differentiation (Remy et al., 1996) .
Here, we report on the identification of another member of the Ets-family of proteins. This protein is most closely related to the murine ER81 Ets-type protein and hence named XER81. During gastrulation, the corresponding gene is most strongly expressed in dorsal and ventral mesoderm, as well as in the future ectoderm. In neurula stages, XER81 expression defines a complex pattern in the anterior neural plate. During later stages of embryogenesis, XER81 transcripts can be detected in the developing kidney, eyes, otic vesicles, specific areas of fore-, mid-and hindbrain, and in the branchial arches. Overexpression of XER81 in Xenopus embryos results in the formation of ectopic tail-like protrusions, as well as in a disturbed eye development. Activin mediated induction of Xegr-1 and gsc is inhibited in animal caps expressing high levels of XER81; in contrast, the Xbra response to activin appears to be unaffected. 
Results

Isolation and characterization of a XER81 encoding cDNA
A cDNA clone encoding an Ets-related protein was isolated from an artificial notochord cDNA library prepared with activin induced animal caps (Grunz and Tacke, 1989) and screened for genes with suggestive expression profiles during Xenopus embryogenesis. Primary sequence analysis identifies a long open reading frame with multiple 5′-in frame stop codons, encoding a 477 amino acid protein (Fig. 1A) . The predicted protein is most closely related to a murine Ets-related protein termed ER81 (Brown and McKnight, 1992) . The Xenopus protein exhibits 86% identity to mouse ER81 and 85% identity in comparison to the closely related human ER81 sequence (Monte et al., 1994) . Sequence alignment with other members of the Ets-protein family described previously in Xenopus laevis, Xl-ets-1, Xlets-2 and Xl-fli (Stiegler et al., 1990; Wolff et al., 1991; Meyer et al., 1993) , reveals only very little sequence homology outside of the Ets-domain region; the Ets-domain of XER81 itself is almost identical to the corresponding region of the murine and human ER81 sequence elements, whereas only a moderate degree of sequence identity is observed in a comparison with the other Xenopus Ets-type proteins (Fig.  1B) . We therefore named the Xenopus protein described here XER81.
Spatial and temporal expression characteristics of XER81
XER81mRNA levels in RNA preparations from staged embryos and from adult tissues were analyzed by RT-PCR (Fig. 2) . The XER81 encoding mRNA was detected in all stages of embryogenesis tested, including the unfertilized egg. In contrast, XER81 RNA concentrations were found to vary significantly in the different adult tissues and organs utilized; highest RNA levels were detected in ovary and kidney, and strong signals were also obtained with neural derivatives such as eye and brain, as well as with the stomach RNA preparation. The other tissues revealed only very low XER81 mRNA levels, hardly above background.
XER81 gene expression was further characterized by whole mount in situ hybridization analysis with staged Xenopus embryos (Fig. 3) . As expected from the RT-PCR experiment described above, XER81 transcripts can already be detected at earliest stages of embryogenesis tested; blastula (stage 9) embryos reveal an even distribution of XER81mRNA in the animal half of the embryo (Fig. 3A , B). During gastrulation (stage 11), highest levels of XER81mRNA are found in the marginal zone (Fig. 3C,  D) . At late gastrula/early neurula (stages 13/14) XER81 also starts to be expressed in the open neural plate, initially rather homogeneously (Fig. 3E ), later defining separate areas (Fig. 3F ). After closure of the neural tube, XER81 stains discrete, non-contiguous elements of fore-, mid-and hindbrain, as well as the prospective lens area; anterior and posterior staining of the mesoderm are maintained, whereas the cement gland is clearly excluded from XER81 expression ( Fig. 3G ,K). Tadpole (stage 32) embryos exhibit XER81 expression in discrete subdomains of fore-, midand hindbrain, in the lens, branchial arches, tail tip and pronephros ( Fig. 3L,P) . Interestingly, within the otic vesicle, which is also positive for XER81, it is only the anterior half of the vesicle that is stained (Fig. 3M) .
In summary, early XER81 expression is detected in the entire animal hemisphere of blastula stage embryos, it is most prominent in the marginal zone during gastrulation and, in addition, it defines discrete elements of the developing central nervous system during neurula and tailbud/tadpole stages of Xenopus embryogenesis. The strong expression observed in the adult kidney correlates with Fig. 2 . XER81 mRNA levels during Xenopus embryogenesis and in adult tissues. RT-PCR reactions were performed with RNA preparations from staged embryos (upper) and from adult organs and tissues (lower) making use of primers specific for either XER81 or histone H4. Abbreviations: bl, bladder; br, brain; ey, eye; fa, fat body; gu, gut; he, heart; in, intestine; ki, kidney; li, liver; lu, lung; mu, muscle; ov, ovary; sc, spinal cord; sk, skin; sp, spleen; st, stomach; te, testis. is a posterior detail from a sagital section, (N-P) gives anterior details from a dorsal to ventral series of horizontal sections. Abbreviations: aen, archencephalon; aet, archenteron; anp, anterior neural plate; anr, anterior neural ridge; ba, branchial arches; bc, blastocoel; bv, brain ventricle; cbc, circumblastoporal collar; cg, cement gland; cnh, chorda-neural hinge; dbl, dorsal blastopore lip; den, deuteroencephalon; enc, epithelial layer of neuroectoderm; end, endoderm; ev, ear vesicle; eym, endodermal yolk mass; eyv, eye vesicle; fb, forebrain; fge, foregut epithelium; hm, head mesenchyme; le, lens; mhb, midbrain/hindbrain boundary; mz, marginal zone; nc, notochord; ne, neuroectoderm; nec, neuroenteric canal; pfb, prospective forebrain; pna, pronephvic anlage; pnc, posterior notochord; pnd, pronephric duct; pw, posterior wall; scf, spinal cord floor; scr, spinal cord roof; snc, sensorial layer of neuroectoderm; tae, tip of archenteron; vbl, ventral blastopore lip; vym, vegetal yolk mass. expression in the developing kidney system during embryogenesis.
XER81 expression can be modulated by dorsalizing and ventralizing peptide growth factors in animal caps
The signalling activity of different peptide growth factors on XER81 gene expression was tested in the Xenopus animal cap assay (Fig. 4) . As expected from the whole mount in situ hybridization data, a low level of XER81 transcripts can be detected in untreated animal caps cultivated to the equivalent of stage 17 (control AC). The peptide growth factors BMP4, activin and bFGF can enhance XER81 transcription reproducibly above background (Fig. 4 and data not shown). The amount of XER81 in animal caps isolated from either ventralized (UV) or dorsalized (LiCl) embryos was not significantly altered.
We also tested if overexpression of different transcription factors which mediate the MAP kinase regulated signal transduction pathway influence XER81 mRNA levels in animal caps. However, neither overexpression of XER81 itself, nor of the serum response factor (SRF), nor of a combination of both proteins could reproducibly increase XER81 mRNA levels (Fig. 4 and data not shown). Similarly, a constitutively active form of SRF (SRF-VP16), which by itself is sufficient to activate the MAP kinase response gene Xegr-1, was not capable of inducing XER 81. The other control genes tested responded as expected.
Interestingly, a weak but highly reproducible increase in Xbra mRNA levels was observed in the presence of XER81 in combination with SRF.
XER81 differentially influences the activin response in animal caps
We further wished to investigate, if increased levels of XER81 can influence the response of the mesodermal marker genes Xegr-1, gsc and Xbra to peptide growth factors in animal caps. For this purpose, XER81 was supplied together with either activin or eFGF (Fig. 5A,B, respectively) . XER81 has no profound effect on the induction of either Xegr-1 or Xbra by eFGF. However, the presence of XER81 was found to strongly inhibit activin mediated induction of either Xegr-1 or gsc. In contrast, the Xbra response to activin was unaffected by the presence of XER81. These observations uncover a segregation in the intracellular signal transduction pathways that lead to activin induced transcription of Xegr-1 and gsc on the one hand, and to induction of Xbra on the other. The exact molecular mechanisms that underlie this differential inhibitory effect remain to be elucidated.
We also addressed the question, if XER81 can function as a ternary complex factor together with SRF on the Xegr-1 promoter in animal caps. If XER81 has such an activity, the finding that an increase in XER81 concentration does not increase the eFGF response of Xegr-1 (Fig. 5B ) may be explained by the presence of low but sufficient amounts of XER81 even in untreated caps (Figs 4 and 5) . We have previously demonstrated that a dominant negative version RT-PCR reactions were performed with RNA preparations from animal caps that had been excised from Xenopus embryos which were injected with mRNA encoding different peptide growth factors (as indicated), mRNA encoding the transcription factor SRF or a constitutively active form of SRF (SRF-VP16), or from embryos which had been either dorsalized (LiCl) or ventralized (UV). Animal cap explants were cultivated to the equivalent of stage 17. Control reactions were performed with total RNA preparations from stage 17 embryos. RT-PCR reactions were performed with RNA preparations from animal caps that had been excised from embryos injected with isolated or combined mRNAs (as indicated). DnElk-1 is a dominant negative variant of the ternary complex factor Elk-1. Animal cap explants were cultivated to the equivalent of stage 10. Control reactions were performed with total RNA preparations from stage 10 embryos.
of the ternary complex factor elk-1 (dn elk-1) can inhibit eFGF mediated induction of Xegr-1 . If XER81 can replace elk-1 in ternary complex formation, coexpression of XER81 with dn elk-1 should rescue the inhibitory effect observed with dn elk-1 alone. However, XER81 is not capable of doing so (Fig. 5B) . This observation correlates with the finding that, in vitro, XER81 is not able to assemble with SRF into a ternary complex on an SRE oligonucleotide that is derived from the 5′-flanking region of the Xegr-1 gene (Bernhard Krain and Alfred Nordheim, personal commun ication).
In summary, overexpression of XER81 in animal caps interferes with activin mediated induction of Xegr-1 and gsc, but not with induction of Xbra. The available experimental evidence provides no support for the idea that XER81 can function as a ternary complex factor.
Overexpression of XER81 in Xenopus embryos results in the formation of ectopic, tail-like protrusions
The effect of XER81 overexpression in Xenopus embryos was tested in a series of microinjection experiments. Injections were either into both blastomeres at the two-cell-stage, or into two ventral or two dorsal blastomeres at the fourcell-stage (Table 1) . The most prominent effect observed in all of these experiments was defective eye development (Fig. 6E ). Transverse sections of such manipulated embryos at the level of the embryonic eye revealed that evagination of rudimentary eye vesicles still occurs, but these appear to be arrested at a premature stage of development (Fig. 6F,G) . Ventral overexpression of XER81 also results in the formation of secondary tail-like protrusions at a high frequency (Table 1 and Fig. 6A) . A histological analysis of these structures reveals that they lack notochord but appear to contain cells with neural character (Fig. 6B,D) . Thus, expression of XER81 alone is sufficient to cause the formation of tail-like protrusions but cannot induce a bona fide tail that would consist of notochord, muscle and neural tissue.
Discussion
XER81 is an Ets-type transcription factor that is expressed in the early embryonic mesoderm of Xenopus embryos and is therefore present in cells which were previously characterized to respond to MAP kinase mediated signalling events. However, the experimental evidence obtained argues against XER81 as being involved in the induction of the eFGF/MAP kinase target genes Xbra and Xegr-1. Instead, ectopic expression of XER81 was found to interfere with induction of the activin response of Xegr-1 and gsc, but not with activin mediated induction of Xbra. In Xenopus embryos, ectopic XER81 was found to result in the formation of tail-like protrusions with neural characteristics, as well as in inhibition of eye development.
Differentially restricted patterns of expression for Etstype proteins in Xenopus embryos
Including XER81, expression patterns for four different Ets-type proteins have been characterized in Xenopus embryos by whole mount in situ hybridization. During early embryogenesis, expression of XER81 appears to overlap with that of Xl-Ets-1 and Xl-Ets-2; all three genes are expressed maternally and they can be detected in animal blastomeres as well as in the marginal zone of blastula stage embryos (Meyer et al., 1997 ; this study). During later stages of embryogenesis, XER81 and Xl-Ets-2 are coexpressed in the pronephros as well as in the neural crest. Xlfli, which is not detected before neurulation, is coexpressed with XER81 in the neural crest and in the tailbud. Other domains of expression appear to be unique to the different members of the Xenopus Ets family, thus defining differentially restricted patterns of expression during embryogenesis. Such differences in the equipment with Ets-type proteins will give different cells distinct responsiveness to an activated MAP kinase cascade. A rather unique feature of XER81 is defined by its expression characteristics in the ear vesicle, where the gene is only active in the anterior half of the vesicle, and the posterior half completely devoid of XER81. This may define an early asymmetry, allowing a differential response to an evenly distributed extracellular signalling molecule in the context of ear development.
Overexpression XER81 and activin signalling
Activin signalling is not assumed to involve Ets-type proteins. Thus, the inhibition of the Xegr-1 and gsc response to activin upon overexpression of XER81 is likely to reflect an indirect mechanism. Other observations have argued for the necessity of an active FGF-MAP kinase signalling pathway for the expression of mesodermal marker genes in response to activin, indicating that FGF signalling provides a permissive environment for activin signalling (LaBonne and Whitman, 1994) . However, the molecular basis for this situation is not understood. One possible explanation for the observed inhibition of activin signalling on gsc and Xegr-1 upon overexpression of XER81 is thus provided by the idea that increased levels of this Ets-type protein might exert a dominant negative effect on other Ets-type proteins that are part of the FGF/MAP kinase cascade. Interestingly, in contrast to gsc and Xegr-1, Xbra induction by activin was found to be unaffected in animal caps overexpressing XER81. It has been demonstrated that the Xbra response occurs at relatively low concentrations of activin, whereas gsc induction requires higher activin levels (Smith et al., 1991) . Taken together, these observations appear to suggest that the differential inhibition of mesodermal marker genes, such as Xbra and gsc, upon overexpression of XER81 may reflect the involvement of different sets of transcription factors in the interpretation of a graded distribution of one and the same signalling molecule.
Formation of tail-like protrusions and inhibition of eye development upon overexpression of XER81
Overexpression of XER81 in Xenopus embryos leads to the partial loss of the eyes, as well as to the formation of taillike protrusions which are devoid of notochordal and somitic tissue. This phenomenon is reminiscent of the effects reported upon induction of ectopic Xbra activity at the beginning of gastrulation (Tada et al., 1997) . Interestingly, ectopic expression of a combination of SRF and XER81 in animal caps was found to correlate with a weak, but highly reproducible induction of Xbra gene transcription. Thus, the phenotype observed in the whole embryo may be caused by XER81 induced ectopic Xbra activity. However, direct target genes for XER81 remain to be identified.
Materials and methods
Isolation of XER81 cDNA
A lZAP Express phage cDNA library was constructed with RNA from artificial notochord tissue, that was obtained by treating disaggregated animal cap cells from stage 8 Xenopus embryos with 20 ng/ml recombinant human activin A (kindly provided by Professor Asashima and Dr. Eto). Part of the randomly primed phage cDNA library was converted into a plasmid library by in vivo excision of the pBK-CMV phagemid from the lZAP Express vector following the protocol provided by the manufacturer (Stratagene). A large scale whole-mount in situ hybridization method was used for screening this plasmid library, in principle as described by Hollemann et al. (1998) . Briefly, single colo-nies were grown in 96-well miniplates. Fluorescein labeled antisense probes were transcribed from templates obtained by PCR amplification of the insert region from these single colonies. Four sets of a special 24-well device for simultaneous in situ hybridization were used per round. Colonies with a suggestive expression pattern were sequenced and matched with the gene bank sequence information. After four rounds of screening, 120 interesting cDNA clones were selected. XER81 is one of these.
Embryos and whole-mount in situ hybridization
Wild-type and albinos Xenopus laevis embryos were obtained by hormone-induced egg laying and in vitro fertilization using standard methods. Whole-mount in situ hybridization was done in principle as described (Harland, 1991) with modifications as reported in Hollemann et al. (1998) . The XER81 probe was transcribed with T7 RNA polymerase from the entire cDNA clone, linearized with EcoRI.
RNA injection and animal cap explants
The entire XER81 coding region was subcloned into the pCS2 + vector (Turner and Weintraub, 1994) . After linearization with NotI, the vector was transcribed in vitro with SP6 RNA polymerase in the presence of m7GpppG to produce capped XER81 transcripts. One nanogram of XER81 RNA, either alone or together with 20 pg of LacZ RNA (Chitnis et al., 1995) , was injected in a volume of 10 nl into two blastomeres of two-cell or four-cell stage Xenopus embryos. As a negative control, embryos were injected with LacZ RNA alone. At various stages, the injected embryos were either fixed for normal histological analysis, or fixed, stained with X-gal to reveal the distribution of the LacZ tracer and then analyzed by whole-mount in situ hybridization. For the animal cap assay, embryos were injected at the two-cell stage into the animal pole of both blastomeres with the following mRNAs: 50 pg zebrafish activinbB (Wittbrodt and Rosa, 1994) ; 5-10 pg eFGF (Isaacs et al., 1992) ; 1-2 ng BMP4 (Köster et al., 1991) ; 500-1000 pg XER81; 500-1000 pg SRF (Mohun et al., 1991) ; 300-600 pg dominant negative ELK ; and 500 pg SRF-VP16 (Dalton and Treisman, 1992; Panitz et al., 1998) . Animal caps were dissected from stage10 embryos. One half of the caps from each RNA injection was immediately frozen for RT-PCR analysis and the other half was cultured in 0.5 × MBS (88 mm NaCl, 1 mM KCl, 0.41 mM CaCl 2 , 0.33 mM Ca(NO 3 ) 2 , 0.82 mM MgSO 4 , 2.4 mM NaHCO 3 , 10 mM HEPES; pH 7.4) and harvested until control siblings had reached stage 17.
RT-PCR
Total RNA from embryos and tissues was isolated with phenol/chloroform extraction and LiCl precipitation (Döring and Stick, 1990) . The Qiagen RNeasy Kit was used for RNA isolation from animal caps. All RNA preparations were treated with DNase I (Boehringer Mannheim) and checked with 35 cycles of histone H4 specific PCR for DNA contamination. RT-PCR was carried out using the Gene Amp RNA PCR kit from Perkin-Elmer. The manufacturer's protocol was followed except that 1 mCi of [a-32 P]dCTP was included in each PCR reaction. One tenth of the PCR products was separated on 6% polyacrylamide gels under denaturing conditions. Dried gels were analyzed using a PhosphorImager and the ImageQuant 2.0 program (Molecular Dynamics). Primer sets for the 3′ untranslated region of XER81 are XER81-UTRF-5′-CATG-GACAGCGCACTTTATTT-3′ and XER81-UTRR-5′-TG-TACCCTTTATGTCCAGAA-3′. The following primer oligonucleotides were utilized: histone H4, F 5′CGGGA-TAACATTCAGGGTATCACT and R 5′ATCCATGGC-GGTAACTGTCTTCCT (Niehrs et al., 1994) ; Xegr-1, F 5′TATCTGCAGATCAGAAACCCT and R 5′CTGGA-GAGGGGTAAGATGTTGAC ; Gsc, F 5′AGGCACAGGACCATCTTCACCG and R 5′CACT-TTTAACCTCTTCGTCCGC (Blumberg et al., 1991) ; Xbra, F 5′TCTCTGGAGTAATGAGTG and R 5′ACA-AAGTCCAGCAGAACCGTA (Smith et al., 1991) .
UV and LiCl treatment
Fertilized eggs were dejellied 30 min after insemination, distributed in PetripermTM petri dishes with UV permeable bottom (Heraeus) and treated with UV transilluminator (Appligene) for 1 min. LiCl treatment was performed by treating embryos with 0.3 M LiCl in 0.1× MBS (88 mM NaCl, 1 mM KCl, 0.41 mM CaCl 2 , 0.33 mM Ca(NO 3 ) 2 , 0.82 mM MgSO 4 , 2.4 mM NaHCO 3 , 10 mM HEPES; pH 7.4) for 8-10 min at the 32-cell stage (Kao and Elinson, 1989 ).
Histological procedures
Vibratome sections were prepared as described previously (Hollemann et al., 1996) . Histological sections were stained with aniline blue/orange G (Grunz, 1970) .
